ATE255583T1 - Metallkomplexe von chlorinderivaten zum abschirmen von röntgenstrahlen - Google Patents

Metallkomplexe von chlorinderivaten zum abschirmen von röntgenstrahlen

Info

Publication number
ATE255583T1
ATE255583T1 AT99929792T AT99929792T ATE255583T1 AT E255583 T1 ATE255583 T1 AT E255583T1 AT 99929792 T AT99929792 T AT 99929792T AT 99929792 T AT99929792 T AT 99929792T AT E255583 T1 ATE255583 T1 AT E255583T1
Authority
AT
Austria
Prior art keywords
rays
shielding
metal complexes
chlorine derivatives
mono
Prior art date
Application number
AT99929792T
Other languages
English (en)
Inventor
Katsuo Aizawa
Shinjiro Sumi
Hirotada Takahashi
Noriaki Aman
Yoshihiko Terayama
Shuichi Gomi
Original Assignee
Meiji Seika Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha filed Critical Meiji Seika Kaisha
Application granted granted Critical
Publication of ATE255583T1 publication Critical patent/ATE255583T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0085Mossbauer effect therapy based on mossbauer effect of a material, i.e. re-emission of gamma rays after absorption of gamma rays by the material; selective radiation therapy, i.e. involving re-emission of ionizing radiation upon exposure to a first ionizing radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/545Heterocyclic compounds
    • A61K47/546Porphyrines; Porphyrine with an expanded ring system, e.g. texaphyrine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
AT99929792T 1998-07-10 1999-07-12 Metallkomplexe von chlorinderivaten zum abschirmen von röntgenstrahlen ATE255583T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP19571798 1998-07-10
PCT/JP1999/003752 WO2000002882A1 (en) 1998-07-10 1999-07-12 Novel x-ray intercepting metal complexes of chlorin derivatives

Publications (1)

Publication Number Publication Date
ATE255583T1 true ATE255583T1 (de) 2003-12-15

Family

ID=16345803

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99929792T ATE255583T1 (de) 1998-07-10 1999-07-12 Metallkomplexe von chlorinderivaten zum abschirmen von röntgenstrahlen

Country Status (9)

Country Link
US (1) US6413495B1 (de)
EP (1) EP1097935B1 (de)
JP (1) JP3692298B2 (de)
AT (1) ATE255583T1 (de)
AU (1) AU748625B2 (de)
CA (1) CA2336582C (de)
DE (1) DE69913351T2 (de)
ES (1) ES2212577T3 (de)
WO (1) WO2000002882A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1166784B1 (de) * 1999-04-02 2008-02-20 Meiji Seika Kaisha Ltd. Inhibition der vaskulären restenose nach einer angioplastie
WO2002041782A2 (en) 2000-11-24 2002-05-30 Koninklijke Philips Electronics N.V. Diagnostic imaging interventional apparatus
AU2002248360A1 (en) 2001-01-16 2002-08-19 Microdexterity Systems, Inc. Surgical manipulator
IL147898A (en) * 2002-01-30 2007-05-15 Yuval Golan A method of treating cancer based on the Ugar effect
CN2885311Y (zh) 2006-01-18 2007-04-04 郑成福 经尿道光动力疗法前列腺治疗仪
US10376711B2 (en) * 2003-03-14 2019-08-13 Light Sciences Oncology Inc. Light generating guide wire for intravascular use
JP4960602B2 (ja) * 2005-04-15 2012-06-27 三鷹光器株式会社 蛍光観察時の明視野光源及びそれを搭載した手術顕微鏡
RU2367434C1 (ru) * 2008-04-22 2009-09-20 Виктор Александрович Борисов Фотосенсибилизатор и способ его получения
RU2406726C1 (ru) * 2009-04-27 2010-12-20 Российская Федерация, от имени которой выступает государственный заказчик - Федеральное агентство по науке и инновациям ПРОИЗВОДНЫЕ 13(1)-N-{2-[N-(КЛОЗО-МОНОКАРБАДОДЕКАБОРАН-1-ИЛ)-МЕТИЛ]АМИНОЭТИЛ}АМИД-15(2),17(3)-ДИМЕТИЛОВОГО ЭФИРА ХЛОРИНА e6, ПРОЯВЛЯЮЩИЕ СВОЙСТВА ФОТОСЕНСИБИЛИЗАТОРА
EP2440247B1 (de) * 2009-06-12 2017-03-08 Erasmus University Medical Center Rotterdam Zielgerichtete nanophotomedikamente zur photodynamischen behandlung von krebs
RU2455039C1 (ru) * 2011-03-14 2012-07-10 Виктор Александрович Борисов Способ фотодинамической терапии злокачественных новообразований
BR112015023568B8 (pt) 2013-03-15 2024-01-02 Ann Mcfarland Sherri Composto à base de metal como composto fotodinâmico
US10149493B2 (en) 2015-04-29 2018-12-11 Corn Products Development, Inc. Flours that improve the crispness of battered potatoes
WO2017053905A1 (en) 2015-09-24 2017-03-30 Abvitro Llc Affinity-oligonucleotide conjugates and uses thereof
PL236093B1 (pl) 2017-07-04 2020-11-30 Dominika Szczepaniak Rozpuszczalne w wodzie kompleksy złota (III), sposób wytwarzania rozpuszczalnych w wodzie kompleksów złota (III) i ich zastosowanie
PL244960B1 (pl) 2021-02-15 2024-04-08 Dominika Szczepaniak Zastosowanie rozpuszczalnych w wodzie kompleksów złota (III)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675338A (en) * 1984-07-18 1987-06-23 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
US4693885A (en) * 1984-07-18 1987-09-15 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
GB8426102D0 (en) * 1984-10-16 1984-11-21 Ici Plc Thermal transfer printing
US4921973A (en) * 1984-12-10 1990-05-01 Johnson Matthey Inc. Platinum complexes and the like
US4815447A (en) * 1985-03-19 1989-03-28 Mills Randell L Mossbauer cancer therapy
US4656186A (en) * 1985-04-30 1987-04-07 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
DE3827940A1 (de) * 1988-08-13 1990-03-01 Schering Ag 13,17-propionsaeure- und propionsaeurederivat- substituierte porphyrin-komplexverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
JP3253663B2 (ja) * 1992-01-20 2002-02-04 タマ生化学株式会社 放射線増感剤

Also Published As

Publication number Publication date
US6413495B1 (en) 2002-07-02
AU748625B2 (en) 2002-06-06
CA2336582C (en) 2006-06-06
ES2212577T3 (es) 2004-07-16
CA2336582A1 (en) 2000-01-20
DE69913351T2 (de) 2004-09-16
WO2000002882A1 (en) 2000-01-20
DE69913351D1 (de) 2004-01-15
EP1097935B1 (de) 2003-12-03
JP3692298B2 (ja) 2005-09-07
EP1097935A1 (de) 2001-05-09
AU4651099A (en) 2000-02-01
EP1097935A4 (de) 2002-01-30

Similar Documents

Publication Publication Date Title
ATE255583T1 (de) Metallkomplexe von chlorinderivaten zum abschirmen von röntgenstrahlen
RU92016479A (ru) Применение 5,10,15,20-тетракис (4-карбоксифенил) порфина для обнаружения и лечения рака легких
EP0461776A3 (en) X-ray analysis apparatus, especially computer tomography apparatus and x-ray target and collimator therefor
ATE274357T1 (de) Texaphyrin-konjugate und ihre anwendiung
RU93051543A (ru) Производные акридина, способ получения, фармацевтическая композиция и способ лечения злокачественных опухолей
DE3751809D1 (de) Intraoperative erstellung des befundes und tumor-therapie mittels endoskop
AU6198086A (en) Agents for use in tumour diagnosis, imaging, localization or treatment
ATE262515T1 (de) Discodermolide verbindungen und deren pharmazeutische zusammensetzungen zur krebstherapie
NO994932L (no) Blandinger og fremgangsmåter for behandling og diagnose av brystkreft
EA200401622A1 (ru) Способы лечения ангиогенеза, роста опухолей и метастазов
ATE306281T1 (de) Antivirales mittel in kombination mit strahlentherapie zur verwendung in der behandlung von krebs
NZ237688A (en) Antibody-cytotoxic immunoconjugate-containing compositions and cancer treatment
NO178571C (no) Analogifremgangsmåte for fremstilling av et bifunksjonelt chelateringsmiddel
Walker et al. Generation of polypeptide-templated gold nanoparticles using ionizing radiation
ATE182077T1 (de) Benzazole derivate als therapeutische mittel
MX9200413A (es) Composicion farmaceutica para el tratamiento y/o diagnostico de tumores de tejido blando.
NO995109D0 (no) Formuleringer inneholdende 1,2,4-benzotriazinoksyder
SE8505315L (sv) Anordning for stralfeltsavskermning vid radioterapi
RU97111568A (ru) Способ лечения онкологических больных
GR880100589A (en) Metalloporfyrines for the inversion of the toxic activity for the tumors treatment
DK1154798T3 (da) Molekyler til behandling og diagnose af tumorer
Oren et al. Exposure to ultraviolet B radiation during phototherapy.
Peterson Prevention of oral complications in cancer patients
ATE291620T1 (de) Mammakarzinom-assoziiertes gen
AU8436791A (en) Use of radioactive metal ion complexes with all-cis-1,3,5-triamino-2,4,6-cyclohexantriol and their derivates for x-ray diagnosis and in tumor therapy as well asfor producing x-ray diagnostic and tumor therapy agents

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties